secwatch.observer — SEC 8-K summary
======================================

Issuer:     ALX ONCOLOGY HOLDINGS INC (ALXO)
CIK:        0001810182
Form:       8-K
Filed at:   2026-06-11T20:02:14+00:00
Accession:  0001193125-26-267472
Event type: other
Sentiment:  neutral
Materiality: 0.12
Item codes: 5.07
LLM model:  deepseek-v4-flash:cloud@v2

ALX Oncology shareholders elect directors, approve executive compensation and auditor at annual meeting
--------------------------------------------------------------------------------

- Vote results: Daniel Curran (100.9M for), Rekha Hemrajani (82.7M for), Chris Takimoto (100.9M for) elected to Class II board.
- Say-on-pay advisory vote passed: 84.5M for, 13.5M against, 2.9M abstain.
- KPMG LLP ratified as independent auditor for FY2026: 119.3M for, 1.8K against, 9.3K abstain.
- All director nominees elected; significant withheld votes for Hemrajani (18.3M) but still elected.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1810182/000119312526267472/0001193125-26-267472-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1810182/000119312526267472/alxo-20260610.htm
  HTML page:      https://secwatch.observer/filing/0001193125-26-267472

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer